Technology Reconstructs the Human Habitat
BEIJING, April 23, 2025 /PRNewswire/ -- When Vietnamese homebuyers wander through three-dimensional property listings in the cloud via VR, and multinational enterprises complete cross-border talent recruitment through virtual reality, FIDOVN—a tech-driven real estate platform deeply rooted in the Vietnamese market—is redefining " Work smart - Life chill " with disruptive technology. Currently, FIDOVN has established Southeast Asia's first VR+AI+Data Hub OMO ecosystem, leveraging digital infrastructure to drive transformative change in a trillion-dollar market in the post-pandemic era. Behind this innovation lies the product and technical prowess of Realsee, a leading tech company providing digital space integrated solutions.
With world-class 3D reconstruction capabilities and a comprehensive hardware-software product portfolio, Realsee has empowered FIDOVN to elevate its service offerings:
Centered on Realsee's self-developed professional Galois 3D LiDAR Camera
and the lightweight Realsee G1 Smart Phone Gimbal, FIDOVN has digitized over 10,000 real estate units. Galois is the industry's first fixed-location laser scanner deployed at scale globally, while the Realsee G1 device enables full spatial replication using only a smartphone. Realsee's advanced editing systems and software suite allow users to annotate, measure, and enhance 3D models while embedding features like navigation, synchronized co-browsing, AI-guided tours, and instant communication. This "what-you-see-is-what-you-get" experience accelerates decision-making, shortening the property transaction cycle. FIDOVN data reveals a 37% VR-driven conversion rate—triple the industry average.
Powered by Realsee's technology, FIDOVN established Southeast Asia's first VR+AI+Data Hub OMO ecosystem, seamlessly integrates online VR tour, virtual interviews, and cloud-based contracts with offline community service hubs covering southern Vietnam's core regions, enabling 30-minute rapid transactions. This dual empowerment for B2B and B2C users has generated a million-level behavioral data asset. According to Ho Chi Minh City's Real Estate Association, agencies adopting VR reduced customer acquisition costs by 45%, while 93% of Gen Z buyers prioritize VR experience when selecting agents (per FIDOVN surveys).
An expat engineer in Binh Duong Province remotely selected a Ho Chi Minh City luxury apartment via AI-driven family-structure recommendations, finalizing cross-border ownership at a local hub. A Vietnamese HR director at a Chinese multinational boosted interview rates by 58% through VR scenarios. "These are real FIDOVN success stories where Realsee's VR technology delivers tangible value," stated Matthew Zhao, FIDOVN's founder.
While most firms optimize workflows with technology, FIDOVN—through Realsee's VR—is reimagining human-space interactions: from VR tour to digital workplaces, smart communities to democratized tech access. In the era of digital-real economy convergence, Realsee's solutions serve as inclusive infrastructure, empowering FIDOVN to make Work smart - Life chill.
FIDOVN marks a pivotal step in Realsee's global expansion. Moving forward, Realsee will continue advancing spatial digitization through technological innovation, delivering future-ready solutions to partners in Vietnam and beyond—unlocking infinite possibilities for intelligent, interconnected spaces.
About Realsee
As a leading tech company providing digital space integrated solutions, Realsee has built the world's largest 3D spatial database by replicating physical spaces, covering over 47 million spaces and boasting over 590 global authorized patents.
Realsee offers digital solutions for your space, spanning from its design and construction stage, to online marketing and visual operation.
Trust Realsee to elevate your real estate transactions, commercial retail, industrial facilities, cultural exhibitions, public affairs, and home decor to the next level.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Realsee Empowers FIDOVN to Revolutionize Vietnam's Real Estate Industry Through VR
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
